EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Natural Progression Of Renal Cell Carcinoma

Esha Marie Gupta, Senior House Officer

Annals of Urology · 15.07.2026 · 18 (1)

DOI: 10.52338/aou.2026.5944 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Urology, online erschienen am 15.07.2026. Verfasst von Esha Marie Gupta und 1 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of small renal masses (SRM) has been evolving over recent years. There is still debate over whether active surveillance can replace radical nephrectomy. We present the case of a woman in her early 90s with an 18cm renal mass that developed over 18 years. The patient was referred to the medical assessment unit. Clinical examination revealed a palpable right upper quadrant mass. A subsequent CT scan of the abdomen and pelvis confirmed a 13cmx17cmx18cm mass arising from the right kidney. The woman had a past medical history of colon adenocarcinoma 18 years prior to this presentation. A CT scan performed post-surgery that year showed an incidental 1.7cm right kidney lesion. This woman was discussed at the Urology MDM. The renal lesion was classified as a Bosniak IV renal mass, indicating it was radiologically malignant. The patient did not wish to undergo any intervention. When last reviewed virtually this year, the patient was well, independent and asymptomatic. A SRM is defined as an incidentally detected contrast enhancing or cystic lesion that is ≤4 cm. Among surgically treated SRMs, 80% are malignant; although most are low-grade tumours, the remaining 20% are benign. According to American Society of Clinical Oncology Guidelines, active surveillance is reasonable for smaller renal lesions in older patients, those with multiple comorbidities, or those who have a limited life expectancy. This patient displayed the natural history of a renal cell carcinoma over an 18-year period. Despite the tumour growth, the patient remained asymptomatic with preserved renal function. Directive Publications Dr. Esha Marie Gupta Image 1. The stages of RCC and degree of invasion (5). Overall five-year survival rates for stage I is 90%; stage II and III is 75% and stage IV is 15%. Image 2. The routes and sites of metastases in RCC (6). The incidence of renal malignancies has increased in recent years due to the increase in incidental findings of small renal

Zitieren

APA

Gupta, E. M., & Officer, S. H. (2026). The Natural Progression Of Renal Cell Carcinoma. Annals of Urology, 18(1). https://doi.org/10.52338/aou.2026.5944

Vancouver

Gupta EM, Officer SH. The Natural Progression Of Renal Cell Carcinoma. Annals of Urology. 2026;18(1). doi:10.52338/aou.2026.5944

BibTeX
@article{Gupta2026,
  author = {Gupta, Esha Marie and Officer, Senior House},
  title = {The Natural Progression Of Renal Cell Carcinoma},
  journal = {Annals of Urology},
  year = {2026},
  volume = {18},
  number = {1},
  doi = {10.52338/aou.2026.5944}
}
Kostenlos starten →